Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
30 participants
INTERVENTIONAL
2009-07-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes?
NCT04402658
Pharmacological Properties of Salmeterol
NCT02558088
Response to Clenbuterol in Humans
NCT03860870
Physiological Response to Salbutamol and Exercise
NCT03902106
Beclomethasone in Healthy Athletes
NCT05352191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To investigate the above mentioned in three groups: healthy men, male asthmatic subjects and male elite athletes with asthma.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
asthmatics
10 male asthmatic subjects
inhaled and oral terbutaline
Inhalation of 2 mg terbutaline as powder as a single dosage. Oral terbutaline 10 mg as a single dosage.
Inhaled: Bricanyl Turbohaler 0.5 mg/dose, MA no. 41076.
Oral: Tablet Bricanyl Retard 5 mg, MA no. 10954.
healthy
10 male healthy volunteers
inhaled and oral terbutaline
Inhalation of 2 mg terbutaline as powder as a single dosage. Oral terbutaline 10 mg as a single dosage.
Inhaled: Bricanyl Turbohaler 0.5 mg/dose, MA no. 41076.
Oral: Tablet Bricanyl Retard 5 mg, MA no. 10954.
elite athletes with asthma
10 elite athletes with asthma.
inhaled and oral terbutaline
Inhalation of 2 mg terbutaline as powder as a single dosage. Oral terbutaline 10 mg as a single dosage.
Inhaled: Bricanyl Turbohaler 0.5 mg/dose, MA no. 41076.
Oral: Tablet Bricanyl Retard 5 mg, MA no. 10954.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inhaled and oral terbutaline
Inhalation of 2 mg terbutaline as powder as a single dosage. Oral terbutaline 10 mg as a single dosage.
Inhaled: Bricanyl Turbohaler 0.5 mg/dose, MA no. 41076.
Oral: Tablet Bricanyl Retard 5 mg, MA no. 10954.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent.
* Age between 18 - 45 years.
* Sex: male.
* Asthma classified as mild to moderate according to GINA guidelines.
* Used beta-2-agonist in minimum 12 months.
Exclusion Criteria
* Respiratory tract infections within the last 2 weeks prior to visit 1 and 2.
* Subjects with other chronic diseases than asthma and allergy.
* Allergy towards the study medicine.
* Use of beta-2-agonist 6 days prior to study day.
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hormone Laboratory, Aker University Hospital, Oslo, Norway
OTHER
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Respiratory Research Unit, Bispebjerg Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jimmi Elers, MD
Role: PRINCIPAL_INVESTIGATOR
Bispebjerg Hospital, Respiratory Research Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bispebjerg Hospital, Respiratory Research Unit
København NV, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TER2009JE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.